Filed: 11/14/2022ACC: 0001104659-22-118263
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 32 equity positions with a total reported market value of $680.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
32
Positions
$680.6K
Total AUM (reported)
80.68M
Total Shares
Allocation by class
COM$594.2K87.3%
SPONS ADR$43.3K6.4%
ORD SH$38.7K5.7%
ADS$4.4K0.7%
Portfolio Concentration
Top 3$226.9K33.3%
4–10$237.9K34.9%
11–25$188.9K27.8%
Rest$26.9K4.0%
Top 3 weight
33.3%
Top 10 weight
68.3%
Voting Authority Distribution
Total shares with voting rights: 80.68M
Sole
Full voting authority
80.68M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole32
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings32
Rows:
Tricida Inc
SOLEShares9.05M
TypeSH
Market value$94.8K
13.93%
Sole
9.05M
Shared
0.00
None
0.00
Aclaris Therapeutics Inc
SOLEShares4.56M
TypeSH
Market value$71.8K
10.55%
Sole
4.56M
Shared
0.00
None
0.00
Cogent Biosciences Inc
SOLEShares4.04M
TypeSH
Market value$60.2K
8.85%
Sole
4.04M
Shared
0.00
None
0.00
Relmada Therapeutics Inc
SOLEShares1.52M
TypeSH
Market value$56.2K
8.26%
Sole
1.52M
Shared
0.00
None
0.00
Viridian Therapeutics Inc
SOLEShares2.13M
TypeSH
Market value$43.7K
6.42%
Sole
2.13M
Shared
0.00
None
0.00
GH Research PLC
SOLEShares3.33M
TypeSH
Market value$38.7K
5.69%
Sole
3.33M
Shared
0.00
None
0.00
DBV Technologies SA
SOLEShares9.30M
TypeSH
Market value$32.5K
4.78%
Sole
9.30M
Shared
0.00
None
0.00
Pliant Therapeutics Inc
SOLEShares1.08M
TypeSH
Market value$22.6K
3.31%
Sole
1.08M
Shared
0.00
None
0.00
Milestone Pharmaceuticals Inc
SOLEShares2.43M
TypeSH
Market value$22.3K
3.28%
Sole
2.43M
Shared
0.00
None
0.00
Terns Pharmaceuticals Inc
SOLEShares3.71M
TypeSH
Market value$21.8K
3.21%
Sole
3.71M
Shared
0.00
None
0.00
Marinus Pharmaceuticals Inc
SOLEShares3.16M
TypeSH
Market value$21.0K
3.08%
Sole
3.16M
Shared
0.00
None
0.00
Gossamer Bio Inc
SOLEShares1.75M
TypeSH
Market value$20.9K
3.07%
Sole
1.75M
Shared
0.00
None
0.00
Annexon Inc
SOLEShares3.22M
TypeSH
Market value$19.9K
2.92%
Sole
3.22M
Shared
0.00
None
0.00
Instil Bio Inc
SOLEShares4.11M
TypeSH
Market value$19.9K
2.92%
Sole
4.11M
Shared
0.00
None
0.00
Akouos Inc
SOLEShares2.80M
TypeSH
Market value$18.9K
2.78%
Sole
2.80M
Shared
0.00
None
0.00
Dice Therapeutics Inc
SOLEShares764.98K
TypeSH
Market value$15.5K
2.28%
Sole
764.98K
Shared
0.00
None
0.00
Aerovate Therapeutics Inc
SOLEShares833.93K
TypeSH
Market value$13.8K
2.03%
Sole
833.93K
Shared
0.00
None
0.00
LianBio
SOLEShares5.38M
TypeSH
Market value$10.8K
1.58%
Sole
5.38M
Shared
0.00
None
0.00
Fulcrum Therapeutics Inc
SOLEShares1.20M
TypeSH
Market value$9.7K
1.43%
Sole
1.20M
Shared
0.00
None
0.00
Inozyme Pharma Inc
SOLEShares2.71M
TypeSH
Market value$7.3K
1.07%
Sole
2.71M
Shared
0.00
None
0.00
Ventyx Biosciences Inc
SOLEShares207.93K
TypeSH
Market value$7.3K
1.07%
Sole
207.93K
Shared
0.00
None
0.00
Prometheus Biosciences Inc
SOLEShares121.66K
TypeSH
Market value$7.2K
1.05%
Sole
121.66K
Shared
0.00
None
0.00
Savara Inc
SOLEShares4.56M
TypeSH
Market value$7.1K
1.04%
Sole
4.56M
Shared
0.00
None
0.00
Provention Bio Inc
SOLEShares1.12M
TypeSH
Market value$5.0K
0.74%
Sole
1.12M
Shared
0.00
None
0.00
Altimmune Inc
SOLEShares369.31K
TypeSH
Market value$4.7K
0.69%
Sole
369.31K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Tricida IncSOLE | COM | 9.05M | SH | $94.8K 13.93% | 9.05M | 0.00 | 0.00 |
Aclaris Therapeutics IncSOLE | COM | 4.56M | SH | $71.8K 10.55% | 4.56M | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | COM | 4.04M | SH | $60.2K 8.85% | 4.04M | 0.00 | 0.00 |
Relmada Therapeutics IncSOLE | COM | 1.52M | SH | $56.2K 8.26% | 1.52M | 0.00 | 0.00 |
Viridian Therapeutics IncSOLE | COM | 2.13M | SH | $43.7K 6.42% | 2.13M | 0.00 | 0.00 |
GH Research PLCSOLE | ORD SH | 3.33M | SH | $38.7K 5.69% | 3.33M | 0.00 | 0.00 |
DBV Technologies SASOLE | SPONS ADR | 9.30M | SH | $32.5K 4.78% | 9.30M | 0.00 | 0.00 |
Pliant Therapeutics IncSOLE | COM | 1.08M | SH | $22.6K 3.31% | 1.08M | 0.00 | 0.00 |
Milestone Pharmaceuticals IncSOLE | COM | 2.43M | SH | $22.3K 3.28% | 2.43M | 0.00 | 0.00 |
Terns Pharmaceuticals IncSOLE | COM | 3.71M | SH | $21.8K 3.21% | 3.71M | 0.00 | 0.00 |
Marinus Pharmaceuticals IncSOLE | COM | 3.16M | SH | $21.0K 3.08% | 3.16M | 0.00 | 0.00 |
Gossamer Bio IncSOLE | COM | 1.75M | SH | $20.9K 3.07% | 1.75M | 0.00 | 0.00 |
Annexon IncSOLE | COM | 3.22M | SH | $19.9K 2.92% | 3.22M | 0.00 | 0.00 |
Instil Bio IncSOLE | COM | 4.11M | SH | $19.9K 2.92% | 4.11M | 0.00 | 0.00 |
Akouos IncSOLE | COM | 2.80M | SH | $18.9K 2.78% | 2.80M | 0.00 | 0.00 |
Dice Therapeutics IncSOLE | COM | 764.98K | SH | $15.5K 2.28% | 764.98K | 0.00 | 0.00 |
Aerovate Therapeutics IncSOLE | COM | 833.93K | SH | $13.8K 2.03% | 833.93K | 0.00 | 0.00 |
LianBioSOLE | SPONS ADR | 5.38M | SH | $10.8K 1.58% | 5.38M | 0.00 | 0.00 |
Fulcrum Therapeutics IncSOLE | COM | 1.20M | SH | $9.7K 1.43% | 1.20M | 0.00 | 0.00 |
Inozyme Pharma IncSOLE | COM | 2.71M | SH | $7.3K 1.07% | 2.71M | 0.00 | 0.00 |
Ventyx Biosciences IncSOLE | COM | 207.93K | SH | $7.3K 1.07% | 207.93K | 0.00 | 0.00 |
Prometheus Biosciences IncSOLE | COM | 121.66K | SH | $7.2K 1.05% | 121.66K | 0.00 | 0.00 |
Savara IncSOLE | COM | 4.56M | SH | $7.1K 1.04% | 4.56M | 0.00 | 0.00 |
Provention Bio IncSOLE | COM | 1.12M | SH | $5.0K 0.74% | 1.12M | 0.00 | 0.00 |
Altimmune IncSOLE | COM | 369.31K | SH | $4.7K 0.69% | 369.31K | 0.00 | 0.00 |
Page 1 of 2